Form D · Biotechnology
AnaBios Corp
San Diego, X1 · CIK 0001517420
Offering snapshot reported Jun 9, 2022 · SEC filing
- Reported sold
- $6.5M Offering amount: $6.5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 25, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 9, 2022 | Initial | $6,499,999 | No comparison | 1 | SEC filing |
| Jun 5, 2020 | Amendment | $1,135,995 | $174,998vs Jan 2, 2020 | 16 | SEC filing |
| Jan 2, 2020 | Initial | $960,997 | No comparison | 11 | SEC filing |
| Jun 21, 2017 | Amendment | $5,753,518 | $624,710vs Jun 3, 2016 | 63 | SEC filing |
| Jun 3, 2016 | Amendment | $5,128,808 | $0vs Jun 1, 2016 | 62 | SEC filing |
| Jun 1, 2016 | Initial | $5,128,808 | No comparison | 62 | SEC filing |
| Sep 12, 2011 | Amendment | $1,318,297 | $214,999vs Sep 2, 2011 | 39 | SEC filing |
| Sep 2, 2011 | Amendment | $1,103,298 | $33,750vs Jun 29, 2011 | 34 | SEC filing |
| Jun 29, 2011 | Amendment | $1,069,548 | $66,250vs Jun 3, 2011 | 30 | SEC filing |
| Jun 3, 2011 | Amendment | $1,003,298 | $203,798vs Apr 6, 2011 | 29 | SEC filing |
| Apr 6, 2011 | Initial | $799,500 | No comparison | 22 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-448689
Source: Form D, filed Jun 9, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Anderson | Director |
| Peter Crowley | Director |
| Richard Erdman | Director |
| Melanie Fan | Director |
| Stephen F. Flaim | Director |
| Andre Ghetti | Executive |
| Andrea P. Ghetti | Executive |
| George Goldsmith | Executive |
| Paul E Miller | Executive |
| Jack Reynolds | Director, Executive |
| Martin Waters | Executive |
| Ian Wisenberg | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3030 Bunker Hill Street
San Diego, X1, 92109
San Diego, X1, 92109